Sentara Norfolk General — Norfolk, Virginia

Sentara Norfolk General is a clinical research site located in Norfolk, Virginia, United States 23507.

Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Sentara Norfolk General has participated in 10 clinical trials with 3 currently active.

Therapeutic areas: Colorectal Cancer Metastatic, Coronary Artery Disease, Peripheral Arterial Disease.

Sponsors: Boston Scientific Corporation, Abbott Medical Devices, ReFlow Medical, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sentara Norfolk General?

Sentara Norfolk General has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sentara Norfolk General conducted?

Sentara Norfolk General has 10 clinical trials on record, with 3 currently active. Their work covers Colorectal Cancer Metastatic, Coronary Artery Disease, Peripheral Arterial Disease.

Is Sentara Norfolk General accredited by Crixeo Clinical Trials?

Sentara Norfolk General has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sentara Norfolk General?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.